By integrating multi-omics data and machine learning, our study uniquely positions PRDX1 as a FAM-linked biomarker, thereby uncovering a novel layer of its functional relevance in BLCA. This evidence concerns the gene PRDX1 and bladder transitional cell carcinoma.